Logo

Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

Share this

Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

Shots:

  • Valeo has started commercial shipment of Redesca and Redesca HP- its low molecular weight heparin ("LMWH") biosimilar across Canada
  • The LMWH is being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism and is now increasingly used as a 1L of defense tool in the fight against COVID-19
  • Redesca is a low molecular weight heparin biosimilar

  Ref: PRNewswire | Image: Valeo

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions